COVID-19 Vax in MS: Lower Response on Certain Medications

New data on COVID vaccination in MS patients has shown a reduced humoral response in patients treated with certain medications — including ocrelizumab, rituximab, and fingolimod — but not others.
Medscape Medical News

Related posts